Etomidate deteriorates the toxicity of advanced glycation end products to human endothelial Eahy926 cells

The Journal of toxicological sciences

Volumn 39, Issue 6, 2014, Pages 887-896

  Wang, Xiaodong ^a   Jin, Arong ^a   An, Min ^a   Ding, Yumei ^a   Tuo, Ya ^a   Qiu, Yi ^a  

^a The Second Affiliated Hospital of Inner Mongolia Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CASPASE 3; CYTOCHROME C; ETOMIDATE; INTRAVENOUS ANESTHETIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; CELL CULTURE; CELL SURVIVAL; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DRUG EFFECTS; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; METABOLISM; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; PHYSIOLOGY;

ANESTHETICS, INTRAVENOUS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; CYTOCHROMES C; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DRUG SYNERGISM; ENDOTHELIAL CELLS; ETOMIDATE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84927686086     PISSN: None     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.39.887     Document Type: Article

References (0)